These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 30649410)

  • 21. Prediction of lung cancer risk in a Chinese population using a multifactorial genetic model.
    Li H; Yang L; Zhao X; Wang J; Qian J; Chen H; Fan W; Liu H; Jin L; Wang W; Lu D
    BMC Med Genet; 2012 Dec; 13():118. PubMed ID: 23228068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cumulative effects of known susceptibility variants to predict primary biliary cirrhosis risk.
    Tang R; Chen H; Miao Q; Bian Z; Ma W; Feng X; Seldin MF; Invernizzi P; Gershwin ME; Liao W; Ma X
    Genes Immun; 2015; 16(3):193-8. PubMed ID: 25569263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of FcGRIIa with Graves' disease: a potential role for dysregulated autoantibody clearance in disease onset/progression.
    Yesmin K; Hargreaves C; Newby PR; Brand OJ; Heward JM; Franklyn JA; Gough SC; Simmonds MJ
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):119-25. PubMed ID: 20148910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic combined effect between CD40-1C>T and CTLA-4+6230G>A polymorphisms in Graves' disease.
    Chen X; Hu Z; Li W; Wu P; Liu M; Bao L; Wu M; Fang S; Xiong W; Chen M; Wu G
    Gene; 2015 Aug; 567(2):154-8. PubMed ID: 25936345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms of IKZF3 Gene and Autoimmune Thyroid Diseases: Associated with Graves' Disease but Not with Hashimoto's Thyroiditis.
    Li L; Ding X; Wang X; Yao Q; Shao X; An X; Yan N; Jiang Y; Wang W; Shi L; Qin Q; Song R; Zhang JA; Sun P
    Cell Physiol Biochem; 2018; 45(5):1787-1796. PubMed ID: 29510406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial growth factor polymorphisms increase the risk of developing Graves' disease.
    Vural P; Baki M; Doğru-Abbasoğlu S; Özderya A; Karadağ B; Uysal M
    Int Immunopharmacol; 2012 Oct; 14(2):133-7. PubMed ID: 22771446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score.
    De Jager PL; Chibnik LB; Cui J; Reischl J; Lehr S; Simon KC; Aubin C; Bauer D; Heubach JF; Sandbrink R; Tyblova M; Lelkova P; ; ; ; ; Havrdova E; Pohl C; Horakova D; Ascherio A; Hafler DA; Karlson EW
    Lancet Neurol; 2009 Dec; 8(12):1111-9. PubMed ID: 19879194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D-binding protein (DBP) gene polymorphism is associated with Graves' disease and the vitamin D status in a Polish population study.
    Kurylowicz A; Ramos-Lopez E; Bednarczuk T; Badenhoop K
    Exp Clin Endocrinol Diabetes; 2006 Jun; 114(6):329-35. PubMed ID: 16868893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TSHR Gene Polymorphisms in the Enhancer Regions Are Most Strongly Associated with the Development of Graves' Disease, Especially Intractable Disease, and of Hashimoto's Disease.
    Fujii A; Inoue N; Watanabe M; Kawakami C; Hidaka Y; Hayashizaki Y; Iwatani Y
    Thyroid; 2017 Jan; 27(1):111-119. PubMed ID: 27762730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incorporating epistasis interaction of genetic susceptibility single nucleotide polymorphisms in a lung cancer risk prediction model.
    Marcus MW; Raji OY; Duffy SW; Young RP; Hopkins RJ; Field JK
    Int J Oncol; 2016 Jul; 49(1):361-70. PubMed ID: 27121382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population.
    Ichimura M; Kaku H; Fukutani T; Koga H; Mukai T; Miyake I; Yamada K; Koda Y; Hiromatsu Y
    Thyroid; 2008 Jun; 18(6):625-30. PubMed ID: 18578611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical evaluation of 3rd generation assay for thyrotropin receptor antibodies: the M22-biotin-based ELISA initiated by Smith.
    Kamijo K; Ishikawa K; Tanaka M
    Endocr J; 2005 Oct; 52(5):525-9. PubMed ID: 16284428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paediatric-onset and adult-onset Graves' disease share multiple genetic risk factors.
    Kuś A; Radziszewski M; Glina A; Szymański K; Jurecka-Lubieniecka B; Pawlak-Adamska E; Kula D; Wawrusiewicz-Kurylonek N; Kuś J; Miśkiewicz P; Płoski R; Bolanowski M; Daroszewski J; Jarząb B; Bossowski A; Bednarczuk T
    Clin Endocrinol (Oxf); 2019 Feb; 90(2):320-327. PubMed ID: 30358895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy.
    Bufalo NE; Dos Santos RB; Marcello MA; Piai RP; Secolin R; Romaldini JH; Ward LS
    J Endocrinol Invest; 2015 May; 38(5):555-61. PubMed ID: 25543543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of chosen polymorphisms rs2476601 a/G - PTPN22, rs1990760 C/T - IFIH1, rs179247 a/G - TSHR in pathogenesis of autoimmune thyroid diseases in children.
    Rydzewska M; Góralczyk A; Gościk J; Wawrusiewicz-Kurylonek N; Bossowska A; Krętowski A; Bossowski A
    Autoimmunity; 2018 Jun; 51(4):183-190. PubMed ID: 29973096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of melatonin receptor gene polymorphisms with Graves' disease.
    Lin JD; Yang SF; Wang YH; Fang WF; Lin YC; Liou BC; Lin YF; Tang KT; Cheng CW
    PLoS One; 2017; 12(9):e0185529. PubMed ID: 28961261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) Gene, Thyroid Stimulating Hormone Receptor (TSHR) Gene and Regulatory T-cells as Risk Factors for Relapse in Patients with Graves Disease.
    Eliana F; Suwondo P; Asmarinah A; Harahap A; Djauzi S; Prihartono J; Pemayun TGD
    Acta Med Indones; 2017 Jul; 49(3):195-204. PubMed ID: 29093229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of CTLA-4 +49 A/G and CT60 Gene Polymorphism with Graves' Disease.
    Fouad NA; Saeed AM; Mahedy AW
    Egypt J Immunol; 2017 Jun; 24(2):63-70. PubMed ID: 29528580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in Gene-Gene Interactions in Graves' Disease Patients Stratified by Age of Onset.
    Jurecka-Lubieniecka B; Bednarczuk T; Ploski R; Krajewska J; Kula D; Kowalska M; Tukiendorf A; Kolosza Z; Jarzab B
    PLoS One; 2016; 11(3):e0150307. PubMed ID: 26943356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms in the interleukin 3 gene show strong association with susceptibility to Graves' disease in Chinese population.
    Chu X; Dong C; Lei R; Sun L; Wang Z; Dong Y; Shen M; Wang Y; Wang B; Zhang K; Yang L; Li Y; Yuan W; Wang Y; Song H; Jin L; Xiong M; Huang W
    Genes Immun; 2009 Apr; 10(3):260-6. PubMed ID: 19262575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.